Co-Designing Strategies To Implement Long-Acting Injectable PrEP for Sexual Minority Men in Chicago: A Study Protocol for an Innovation Tournament and Implementation Mapping

March 25, 2024

Implementation Science Communications

Read the full article

Authors

Amelia E. Van Pelt, Elizabeth Casline, Gregory Phillips 2nd, Jorge Cestou, Brian Mustanski, Grace Cook, Rinad S. Beidas

CHIBE Experts

Research Areas

Other Research Areas

How Can a Behavioral Economics Lens Contribute to Implementation Science?

Implementation Science

April 26, 2024
Friends with Health Benefits: A Field Experiment

Management Science

April 17, 2024
Adolescent Preferences for a Pediatric Primary Care-Based Sexually Transmitted Infection and HIV Prevention Intervention

Journal of Adolescent Health

March 24, 2024
Measuring Quality-Weighted Hospital-Free-Days in Acute Respiratory Failure: A Modified Delphi Study

Annals of the American Thoracic Society

March 20, 2024
Field Testing the Transferability of Behavioural Science Knowledge on Promoting Vaccinations

Nature Human Behaviour

March 14, 2024
The Next Decade of Healthcare

Healthcare

February 29, 2024
Health Care Resource Utilization and Costs Associated With Diagnosed Medication Overuse Headache and Potential Acute Medication Overuse in Individuals With Migraine

Cephalalgia

February 27, 2024
Evaluating the Implementation of a Community Health Worker-Delivered Intervention Integrating Asthma Care in West Philadelphia Public Schools

Journal of Asthma

February 9, 2024
Real-World Survival, Healthcare Resource Utilization, and Costs Among U.S. Elderly Patients With Diffuse Large B-Cell Lymphoma (DLBCL) Treated With R-GemOx in the Relapsed/Refractory Setting

Clinical Lymphoma Myeloma Leukemia

February 8, 2024
A Social Network Analysis of Hemodialysis Clinics: Attitudes Towards Living Donor Kidney Transplant Among Influential Patients

Kidney360

February 7, 2024
Officer-Involved Killings of Unarmed Black People and Racial Disparities in Sleep Health

JAMA Internal Medicine

February 5, 2024
Real-World Analysis of Adverse Event Rates After Initiation of Ibrutinib Among Medicare Beneficiaries With Chronic Lymphocytic Leukemia

Cancer Medicine

February 1, 2024